Cytokine and growth factor activation in vivo and in vitro after spinal cord injury

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Garcia, Elisa ^a   Aguilar Cevallos, Jorge ^a   Silva Garcia, Raul ^b   Ibarra, Antonio ^a  

^a UNIVERSIDAD ANÁHUAC   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; FREE RADICAL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUTAMIC ACID; GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTROPHIN; SODIUM; TUMOR NECROSIS FACTOR ALPHA; FIBROBLAST GROWTH FACTOR 1;

APOPTOSIS; CALCIUM CELL LEVEL; DEMYELINATION; DISEASE COURSE; EDEMA; EXCITOTOXICITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOLECULAR PATHOLOGY; MOLECULE; NEUROFILAMENT; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SODIUM CELL LEVEL; SPINAL CORD ATROPHY; SPINAL CORD BLOOD FLOW; SPINAL CORD INJURY; TH1 CELL; TH17 CELL; ANIMAL; IMMUNOLOGY; METABOLISM;

ANIMALS; CYTOKINES; EDEMA; FIBROBLAST GROWTH FACTOR 1; HUMANS; INFLAMMATION; SPINAL CORD INJURIES; TH1 CELLS; TH17 CELLS;

EID: 84978766827     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/9476020     Document Type: Review

References (237)

1. S. Dalbayrak, O. Yaman, and T. Yilmaz, "Current and future surgery strategies for spinal cord injuries, " World Journal of Orthopaedics, vol. 6, no. 1, pp. 34-41, 2015.
2. C. A. Oyinbo, "Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade, " Acta Neurobiologiae Experimentalis, vol. 71, no. 2, pp. 281-299, 2011.
3. A. M. Siddiqui, M. Khazaei, and M. G. Fehlings, "Sensorimotor rehabilitation: at the crossroads of basic and clinical, " in Progress in Brain Research, pp. 15-54, Elsevier, New York, NY, USA, 2015.
4. A. M. Siddiqui, M. Khazaei, and M. G. Fehlings, "Translating mechanisms of neuroprotection, regeneration, and repair to treatment of spinal cord injury, " Progress in Brain Research, vol. 218, pp. 15-54, 2015.
5. C. Profyris, S. S. Cheema, D. Zang, M. F. Azari, K. Boyle, and S. Petratos, "Degenerative and regenerative mechanisms governing spinal cord injury, " Neurobiology of Disease, vol. 15, no. 3, pp. 415-436, 2004.
6. Y. H. Ahn, G. Lee, and S. K. Kang, "Molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival, " Biochemical and Biophysical Research Communications, vol. 348, no. 2, pp. 560-570, 2006.
7. D. Bastien, V. B. Landete, M. Lessard, et al., "IL-1γ gene deletion protects oligodendrocytes after spinal cord injury through upregulation of the survival factor Tox3, " The Journal of Neuroscience, vol. 35, no. 30, pp. 10715-10730, 2015.
8. M. A. Erickson, K. Dohi, and W. A. Banks, "Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier, " NeuroImmunoModulation, vol. 19, no. 2, pp. 121-130, 2012.
9. K. Uchida, H. Nakajima, T. Hirai, et al., "Microarray analysis of expression of cell death-associated genes in rat spinal cord cells exposed to cyclic tensile stresses in vitro, " BMC Neuroscience, vol. 11, article 84, 2010.
10. G. Ramesh, A. G. Maclean, and M. T. Philipp, "Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain, " Mediators of Inflammation, vol. 2013, Article ID480739, 20 pages, 2013.
11. G. E. Landreth, Growth Factors Are Essential for Nervous System Development and Function, Lippincott-Raven, 1999.
12. X. E. Dereka, C. E. Markopoulou, and I. A. Vrotsos, "Role of growth factors on periodontal repair, " Growth Factors, vol. 24, no. 4, pp. 260-267, 2006.
13. X.-Q. Li, H.-W. Lv, W.-F. Tan, B. Fang, H. Wang, and H. Ma, "Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats, " Journal of Neuroinflammation, vol. 11, article 62, 2014.
14. D. N. Xanthos, I. Pungel, G. Wunderbaldinger, and J. Sandkuhler, "Effects of peripheral inflammation on the bloodspinal cord barrier, " Molecular Pain, vol. 8, article 44, 2012.
15. V. Bartanusz, D. Jezova, B. Alajajian, and M. Digicaylioglu, "The blood-spinal cord barrier: morphology and clinical implications, " Annals of Neurology, vol. 70, no. 2, pp. 194-206, 2011.
16. P. Losey, C. Young, E. Krimholtz, R. Bordet, and D. C. Anthony, "The role of hemorrhage following spinal-cord injury, " Brain Research, vol. 1569, pp. 9-18, 2014.
17. D. J. Donnelly and P. G. Popovich, "Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury, " Experimental Neurology, vol. 209, no. 2, pp. 378-388, 2008.
18. D. M. Cohen, C. B. Patel, P. Ahobila-Vajjula, et al., "Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI, "NMRin Biomedicine, vol. 22, no. 3, pp. 332-341, 2009.
19. W. D. Whetstone, J.-Y. C. Hsu, M. Eisenberg, Z. Werb, and L. J. Noble-Haeusslein, "Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing, " Journal of Neuroscience Research, vol. 74, no. 2, pp. 227-239, 2003.
20. L. J. Noble and J. R. Wrathall, "Distribution and time course of protein extravasation in the rat spinal cord after contusive injury, " Brain Research, vol. 482, no. 1, pp. 57-66, 1989.
21. W. Pan and A. J. Kastin, "Cytokine transport across the injured blood-spinal cord barrier, " Current Pharmaceutical Design, vol. 14, no. 16, pp. 1620-1624, 2008.
22. L.-Y. Chi, J. Yu, H. Zhu, X.-G. Li, S.-G. Zhu, and M. S. Kindy, "The dual role of tumor necrosis factor-alpha in the pathophysiology of spinal cord injury, " Neuroscience Letters, vol. 438, no. 2, pp. 174-179, 2008.
23. W. Pan, C. Cain, Y. Yu, and A. J. Kastin, "Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury, " Journal of Neuroimmunology, vol. 174, no. 1-2, pp. 119-125, 2006.
24. B. J. Kerr and P. H. Patterson, "Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse, " Experimental Neurology, vol. 188, no. 2, pp. 391-407, 2004.
25. M. F. Azari, C. Profyris, T. Karnezis, et al., "Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury, " Journal of Neuropathology and Experimental Neurology, vol. 65, no. 9, pp. 914-929, 2006.
26. S. Li and C. H. Tator, "Effects of MK801 on evoked potentials, spinal cord blood flow and cord edema in acute spinal cord injury in rats, " Spinal Cord, vol. 37, no. 12, pp. 820-832, 1999.
27. H. S. Sharma, "Pathophysiology of blood-spinal cord barrier in traumatic injury and repair, " Current Pharmaceutical Design, vol. 11, no. 11, pp. 1353-1389, 2005.
28. C. Akiyama, T. Yuguchi, M. Nishio, et al., "Src family kinase inhibitor PP1 improves motor function by reducing edema after spinal cord contusion in rats, " Acta Neurochirurgica. Supplement, vol. 86, pp. 421-423, 2003.
29. H.-Q. Long, G.-S. Li, X. Cheng, J.-H. Xu, and F.-B. Li, "Role of hypoxia-induced VEGF in blood-spinal cord barrier disruption in chronic spinal cord injury, " Chinese Journal of Traumatology, vol. 18, no. 5, pp. 293-295, 2015.
30. M. Lemke, P. Demediuk, T. K. McIntosh, R. Vink, and A. I. Faden, "Alterations in tissue Mg++, Na+ and spinal cord edema following impact trauma in rats, " Biochemical and Biophysical Research Communications, vol. 147, no. 3, pp. 1170-1175, 1987.
31. W. Young and I. Koreh, "Potassium and calcium changes in injured spinal cords, " Brain Research, vol. 365, no. 1, pp. 42-53, 1986.
32. S. K. Agrawal, R. Nashmi, and M. G. Fehlings, "Role of L-and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury, " Neuroscience, vol. 99, no. 1, pp. 179-188, 2000.
33. I. Wagner, B. Volbers, M. J. Hilz, S. Schwab, A. Doerfler, and D. Staykov, "Radiopacity of intracerebral hemorrhage correlates with perihemorrhagic edema, " European Journal of Neurology, vol. 19, no. 3, pp. 525-528, 2012.
34. C. R. Marmarou, X. Liang, N. H. Abidi, et al., "Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury, " Brain Research, vol. 1581, pp. 89-102, 2014.
35. M. Simard and M. Nedergaard, "The neurobiology of glia in the context of water and ion homeostasis, " Neuroscience, vol. 129, no. 4, pp. 877-896, 2004.
36. M. Xiao and G. Hu, "Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders, " CNS Neuroscience andTherapeutics, vol. 20, no. 5, pp. 385-390, 2014.
37. J. Badaut, A. M. Fukuda, A. Jullienne, and K. G. Petry, "Aquaporin and brain diseases, " Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 5, pp. 1554-1565, 2014.
38. P. M. Casillas-Espinosa, K. L. Powell, and T. J. O'Brien, "Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy, " Epilepsia, vol. 53, supplement 9, pp. 41-58, 2012.
39. E. Nanou, M. H. Alpert, S. Alford, and A. El-Manira, "Differential regulation of synaptic transmission by pre-and postsynaptic SK channels in the spinal locomotor network, " Journal of Neurophysiology, vol. 109, no. 12, pp. 3051-3059, 2013.
40. N. Weiss, "The N-type voltage-gated calcium channel: when a neuron reads a map, " Journal of Neuroscience, vol. 28, no. 22, pp. 5621-5622, 2008.
41. R. S. Hammond, C. T. Bond, T. Strassmaier, et al., "Smallconductance Ca2+-activatedK+ channel type 2 (SK2)modulates hippocampal learning, memory, and synaptic plasticity, " The Journal of Neuroscience, vol. 26, no. 6, pp. 1844-1853, 2006.
42. M. J. Berridge, M. D. Bootman, and H. L. Roderick, "Calcium signalling: dynamics, homeostasis and remodelling, " Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 517-529, 2003.
43. G. J. Augustine, F. Santamaria, and K. Tanaka, "Local calcium signaling in neurons, " Neuron, vol. 40, no. 2, pp. 331-346, 2003.
44. J. R. Plemel, M. B. Keough, G. J. Duncan, et al., "Remyelination after spinal cord injury: is it a target for repair?" Progress in Neurobiology, vol. 117, pp. 54-72, 2014.
45. S. Feske, "Calcium signalling in lymphocyte activation and disease, " Nature Reviews Immunology, vol. 7, no. 9, pp. 690-702, 2007.
46. R. Sattler and M. Tymianski, "Molecular mechanisms of calcium-dependent excitotoxicity, " Journal of Molecular Medicine, vol. 78, no. 1, pp. 3-13, 2000.
47. R. M. Sapolsky, "Cellular defenses against excitotoxic insults, " Journal of Neurochemistry, vol. 76, no. 6, pp. 1601-1611, 2001.
48. M. L. Cotrina and M. Nedergaard, "Physiological and pathological functions of P2X7 receptor in the spinal cord, " Purinergic Signalling, vol. 5, no. 2, pp. 223-232, 2009.
49. W. Peng, M. L. Cotrina, X. Han, et al., "Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 30, pp. 12489-12493, 2009.
50. A. Marcillo, B. Frydel, H. M. Bramlett, and W. D. Dietrich, "A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury, " Experimental Neurology, vol. 233, no. 2, pp. 687-692, 2012.
51. S. Ozawa, H. Kamiya, and K. Tsuzuki, "Glutamate receptors in the mammalian central nervous system, " Progress in Neurobiology, vol. 54, no. 5, pp. 581-618, 1998.
52. L.-N. Zhang, Y.-J. Sun, L.-X. Wang, and Z.-B. Gao, "Glutamate transporters/Na+, K+-ATPase involving in the neuroprotective effect as a potential regulatory target of glutamate uptake, " Molecular Neurobiology, vol. 53, no. 2, pp. 1124-1131, 2015.
53. G. Olmos and J. Llado, "Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity, " Mediators of Inflammation, vol. 2014, Article ID 861231, 12 pages, 2014.
54. M. D. Christensen, A. W. Everhart, J. T. Pickelman, and C. E. Hulsebosch, "Mechanical and thermal allodynia in chronic central pain following spinal cord injury, " Pain, vol. 68, no. 1, pp. 97-107, 1996.
55. J. T. Weber, "Calciumhomeostasis following traumatic neuronal injury, " Current Neurovascular Research, vol. 1, no. 2, pp. 151-171, 2004.
56. A. Mehta, M. Prabhakar, P. Kumar, R. Deshmukh, and P. L. Sharma, "Excitotoxicity: bridge to various triggers in neurodegenerative disorders, " European Journal of Pharmacology, vol. 698, no. 1-3, pp. 6-18, 2013.
57. O. Nesic, N. M. Svrakic, G.-Y. Xu, et al., "DNA microarray analysis of the contused spinal cord: effect of NMDA receptor inhibition, " Journal of Neuroscience Research, vol. 68, no. 4, pp. 406-423, 2002.
58. A. Cox, A. Varma, and N. Banik, "Recent advances in the pharmacologic treatment of spinal cord injury, " Metabolic Brain Disease, vol. 30, no. 2, pp. 473-482, 2015.
59. J. D. Rothstein, M. Dykes-Hoberg, C. A. Pardo, et al., "Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate, " Neuron, vol. 16, no. 3, pp. 675-686, 1996.
60. M. M. Mortazavi, K. Verma, O. A. Harmon, et al., "The microanatomy of spinal cord injury: a review, " Clinical Anatomy, vol. 28, no. 1, pp. 27-36, 2015.
61. J. L. Takahashi, F. Giuliani, C. Power, Y. Imai, and V. W. Yong, "Interleukin-1γ promotes oligodendrocyte death through glutamate excitotoxicity, " Annals of Neurology, vol. 53, no. 5, pp. 588-595, 2003.
62. M. Pickering, D. Cumiskey, and J. J. O'Connor, "Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system, " Experimental Physiology, vol. 90, no. 5, pp. 663-670, 2005.
63. L. Xiao, Z.-L. Ma, X. Li, Q.-X. Lin, H.-P. Que, and S.-J. Liu, "cDNA microarray analysis of spinal cord injury and regeneration related genes in rat, " Sheng Li Xue Bao, vol. 57, no. 6, pp. 705-713, 2005.
64. H. Kirschke and B. Wiederanders, "Cathepsin S and related lysosomal endopeptidases, " Methods in Enzymology, vol. 244, pp. 500-511, 1994.
65. J. P. Liuzzo, S. S. Petanceska, D. Moscatelli, and L. A. Devi, "Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions, " Molecular Medicine, vol. 5, no. 5, pp. 320-333, 1999.
66. D. Aviezer, D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon, "Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis, " Cell, vol. 79, no. 6, pp. 1005-1013, 1994.
67. C. A. Colton, C. M. Brown, and M. P. Vitek, "Sex steroids, APOE genotype and the innate immune system, " Neurobiology of Aging, vol. 26, no. 3, pp. 363-372, 2005.
68. Q. Xu, D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang, "Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS, " The Journal of Neuroscience, vol. 28, no. 6, pp. 1452-1459, 2008.
69. J.-F. Wang, Y. Li, J.-N. Song, and H.-G. Pang, "Role of hydrogen sulfide in secondary neuronal injury, " Neurochemistry International, vol. 64, no. 1, pp. 37-47, 2014.
70. K. H. Cheeseman and T. F. Slater, "An introduction to free radical biochemistry, " BritishMedical Bulletin, vol. 49, no. 3, pp. 481-493, 1993.
71. Q. Kong and C.-L. G. Lin, "Oxidative damage to RNA: mechanisms, consequences, and diseases, " Cellular and Molecular Life Sciences, vol. 67, no. 11, pp. 1817-1829, 2010.
72. S. Ljubisavljevic, "Oxidative stress and neurobiology of demyelination, " MolecularNeurobiology, vol. 53, no. 1, pp. 744-758, 2016.
73. M. Bains and E. D. Hall, "Antioxidant therapies in traumatic brain and spinal cord injury, " Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1822, no. 5, pp. 675-684, 2012.
74. H. B. Demopoulos, E. S. Flamm, M. L. Seligman, D. D. Pietronigro, J. Tomasula, and V. DeCrescito, "Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injury, " Canadian Journal of Physiology and Pharmacology, vol. 60, no. 11, pp. 1415-1424, 1982.
75. A. J. Banes, M. Tsuzaki, J. Yamamoto, et al., "Mechanoreception at the cellular level: the detection, interpretation, and diversity of responses to mechanical signals, " Biochemistry and Cell Biology, vol. 73, no. 7-8, pp. 349-365, 1995.
76. D. Liu, X. Ling, J. Wen, and J. Liu, "The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein, " Journal of Neurochemistry, vol. 75, no. 5, pp. 2144-2154, 2000.
77. P. G. Sullivan, S. Krishnamurthy, S. P. Patel, J. D. Pandya, and A. G. Rabchevsky, "Temporal characterization ofmitochondrial bioenergetics after spinal cord injury, " Journal of Neurotrauma, vol. 24, no. 6, pp. 991-999, 2007.
78. K. M. Carrico, R. Vaishnav, and E. D. Hall, "Temporal and spatial dynamics of peroxynitrite-induced oxidative damage after spinal cord contusion injury, " Journal of Neurotrauma, vol. 26, no. 8, pp. 1369-1378, 2009.
79. R. A. Vaishnav, I. N. Singh, D. M. Miller, and E. D. Hall, "Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function, " Journal of Neurotrauma, vol. 27, no. 7, pp. 1311-1320, 2010.
80. E. D. Hall, "Antioxidant therapies for acute spinal cord injury, " Neurotherapeutics, vol. 8, no. 2, pp. 152-167, 2011.
81. M. Fitzgerald, "Strategies to limit dysmyelination during secondary degeneration following neurotrauma, " Neural Regeneration Research, vol. 9, no. 11, pp. 1096-1099, 2014.
82. E. B. Stubbs Jr., M. A. Fisher, and G. J. Siegel, "Anti-tubulin antibodies in a sensorimotor neuropathy patient alter tubulin polymerization, " Acta Neuropathologica, vol. 95, no. 3, pp. 302-305, 1998.
83. M. Xu, Y.-K. Ng, and S.-K. Leong, "Neuroprotective and neurodestructive functions of nitric oxide after spinal cord hemisection, " Experimental Neurology, vol. 161, no. 2, pp. 472-480, 2000.
84. H. S. Sharma, J. Westman, Y. Olsson, and P. Alm, "Involvement of nitric oxide in acute spinal cord injury: an immunocytochemical study using light and electron microscopy in the rat, " Neuroscience Research, vol. 24, no. 4, pp. 373-384, 1996.
85. T. M. Dawson, J. Zhang, V. L. Dawson, and S. H. Snyder, "Nitric oxide: cellular regulation and neuronal injury, " in Neural Regeneration, chapter 30, pp. 365-369, Elsevier BV, 1994.
86. T. J. Guzik, S. Mussa, D. Gastaldi, et al., "Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase, " Circulation, vol. 105, no. 14, pp. 1656-1662, 2002.
87. P. Lopez-Jaramillo, "Calcium, nitric oxide, and preeclampsia, " Seminars in Perinatology, vol. 24, no. 1, pp. 33-36, 2000.
88. Y. Li, L. Liu, S. W. Barger, R. E. Mrak, and W. S. T. Griffin, "Vitamin E suppression ofmicroglial activation is neuroprotective, " Journal ofNeuroscience Research, vol. 66, no. 2, pp. 163-170, 2001.
89. R. Gonzalez, J. Glaser, M. T. Liu, T. E. Lane, and H. S. Keirstead, "Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury, " Experimental Neurology, vol. 184, no. 1, pp. 456-463, 2003.
90. A. K. Abbas, A. H. Lichtman, and S. Pillai, "Basic immunology: functions and disorders of the immune system, " in Immunology, pp. 173-187, 2012.
91. D. Male, J. Brostoff, D. B. Roth, and I. Roitt, "Antibodies, " in Immunology, pp. 59-86, Elsevier BV, 2006.
92. S. David, J. G. Zarruk, and N. Ghasemlou, "Inflammatory pathways in spinal cord injury, " International Review of Neurobiology, vol. 106, pp. 127-152, 2012.
93. M. Hashimoto, A. Nitta, H. Fukumitsu, H. Nomoto, L. Shen, and S. Furukawa, "Inflammation-induced GDNF improves locomotor function after spinal cord injury, " NeuroReport, vol. 16, no. 2, pp. 99-102, 2005.
94. N. A. Silva, N. Sousa, R. L. Reis, and A. J. Salgado, "From basics to clinical: a comprehensive reviewon spinal cord injury, " Progress in Neurobiology, vol. 114, pp. 25-57, 2014.
95. J. Glaser, R. Gonzalez, V. M. Perreau, C. W. Cotman, and H. S. Keirstead, "Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury, " Journal of Neuroscience Research, vol. 77, no. 5, pp. 701-708, 2004.
96. P. G. Popovich, P. Wei, and B. T. Stokes, "Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats, " Journal of Comparative Neurology, vol. 377, no. 3, pp. 443-464, 1997.
97. J. C. Gensel and B. Zhang, "Macrophage activation and its role in repair and pathology after spinal cord injury, " Brain Research, vol. 1619, pp. 1-11, 2015.
98. J. M. Sroga, T. B. Jones, K. A. Kigerl, V. M. McGaughy, and P. G. Popovich, "Rats and mice exhibit distinct inflammatory reactions after spinal cord injury, " Journal of Comparative Neurology, vol. 462, no. 2, pp. 223-240, 2003.
99. E. D. Hall and J. E. Springer, "Neuroprotection and acute spinal cord injury: a reappraisal, " NeuroRx, vol. 1, no. 1, pp. 80-100, 2004.
100. J. E. Burda, A. M. Bernstein, and M. V. Sofroniew, "Astrocyte roles in traumatic brain injury, " Experimental Neurology, vol. 275, part 3, pp. 305-315, 2016.
101. A. Fernandes, L. Miller-Fleming, and T. F. Pais, "Microglia and inflammation: conspiracy, controversy or control?" Cellular and Molecular Life Sciences, vol. 71, no. 20, pp. 3969-3985, 2014.
102. D. J. Loane and K. R. Byrnes, "Role of microglia in neurotrauma, " Neurotherapeutics, vol. 7, no. 4, pp. 366-377, 2010.
103. L. Yang, P. C. Blumbergs, N. R. Jones, J. Manavis, G. T. Sarvestani, and M. N. Ghabriel, "Early expression and cellular localization of proinflammatory cytokines interleukin-1γ, interleukin-6, and tumor necrosis factor-β in human traumatic spinal cord injury, " Spine, vol. 29, no. 9, pp. 966-971, 2004.
104. I. Pineau and S. Lacroix, "Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved, " Journal of Comparative Neurology, vol. 500, no. 2, pp. 267-285, 2007.
105. Y. Taoka, K. Okajima, M. Uchiba, et al., "Role of neutrophils in spinal cord injury in the rat, " Neuroscience, vol. 79, no. 4, pp. 1177-1182, 1997.
106. I. Pineau, L. Sun, D. Bastien, and S. Lacroix, "Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion, " Brain, Behavior, and Immunity, vol. 24, no. 4, pp. 540-553, 2010.
107. D. P. Stirling and V. W. Yong, "Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry, " Journal of Neuroscience Research, vol. 86, no. 9, pp. 1944-1958, 2008.
108. A. Trivedi, A. D. Olivas, and L. J. Noble-Haeusslein, "Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes, " Clinical Neuroscience Research, vol. 6, no. 5, pp. 283-292, 2006.
109. W. G. Glass, M. T. Liu, W. A. Kuziel, and T. E. Lane, "Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus, " Virology, vol. 288, no. 1, pp. 8-17, 2001.
110. D. C. Anthony and Y. Couch, "The systemic response to CNS injury, " Experimental Neurology, vol. 258, pp. 105-111, 2014.
111. J. Gehrmann, Y. Matsumoto, and G. W. Kreutzberg, "Microglia: intrinsic immuneffector cell of the brain, " Brain Research Reviews, vol. 20, no. 3, pp. 269-287, 1995.
112. B. Wu, D. Matic, N. Djogo, E. Szpotowicz, M. Schachner, and I. Jakovcevski, "Improved regeneration after spinal cord injury in mice lacking functional T-and B-lymphocytes, " Experimental Neurology, vol. 237, no. 2, pp. 274-285, 2012.
113. Y. Abe, H. Nakamura, O. Yoshino, T. Oya, and T. Kimura, "Decreased neural damage after spinal cord injury in tPAdeficient mice, " Journal of Neurotrauma, vol. 20, no. 1, pp. 43-57, 2003.
114. A. R. Blight, "Macrophages and inflammatory damage in spinal cord injury, " Journal of Neurotrauma, vol. 9, supplement 1, pp. S83-S91, 1992.
115. D. Wu, O. Miyamoto, S. Shibuya, et al., "Different expression of macrophages and microglia in rat spinal cord contusion injurymodel atmorphological and regional levels, " Acta Medica Okayama, vol. 59, no. 4, pp. 121-127, 2005.
116. J. R. Bethea and D. W. Dietrich, "Targeting the host inflammatory response in traumatic spinal cord injury, " Current Opinion in Neurology, vol. 15, no. 3, pp. 355-360, 2002.
117. P. G. Popovich, N. Van Rooijen, W. F. Hickey, G. Preidis, and V. McGaughy, "Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury, " Experimental Neurology, vol. 182, no. 2, pp. 275-287, 2003.
118. I. Shaked, D. Tchoresh, R. Gersner, et al., "Protective autoimmunity: interferon-α enables microglia to remove glutamate without evoking inflammatory mediators, " Journal of Neurochemistry, vol. 92, no. 5, pp. 997-1009, 2005.
119. G. W. Kreutzberg, "Microglia: a sensor for pathological events in the CNS, " Trends in Neurosciences, vol. 19, no. 8, pp. 312-318, 1996.
120. S. U. Kim and J. De Vellis, "Microglia in health and disease, " Journal of Neuroscience Research, vol. 81, no. 3, pp. 302-313, 2005.
121. A.-J. Hao, S. T. Dheen, and E.-A. Ling, "Expression of macrophage colony-stimulating factor and its receptor in microglia activation is linked to teratogen-induced neuronal damage, " Neuroscience, vol. 112, no. 4, pp. 889-900, 2002.
122. K. Nakajima and S. Kohsaka, "Microglia: activation and their significance in the central nervous system, " Journal of Biochemistry, vol. 130, no. 2, pp. 169-175, 2001.
123. K. Nakajima, S. Honda, Y. Tohyama, Y. Imai, S. Kohsaka, and T. Kurihara, "Neurotrophin secretion fromcultured microglia, " Journal of Neuroscience Research, vol. 65, no. 4, pp. 322-331, 2001.
124. P. G. Popovich, Z. Guan, V. McGaughy, L. Fisher, W. F. Hickey, and D. M. Basso, "Theneuropathological and behavioral consequences of intraspinal microglial/macrophage activation, " Journal of Neuropathology and Experimental Neurology, vol. 61, no. 7, pp. 623-633, 2002.
125. A. Gratchev, K. Schledzewski, P. Guillot, and S. Goerdt, "Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing, " Skin Pharmacology and Applied Skin Physiology, vol. 14, no. 5, pp. 272-279, 2001.
126. O. Lazarov-Spiegler, A. S. Solomon, A. B. Zeev-Brann, D. L. Hirschberg, V. Lavie, and M. Schwartz, "Transplantation of activated macrophages overcomes central nervous system regrowth failure, " The FASEB Journal, vol. 10, no. 11, pp. 1296-1302, 1996.
127. O. Rapalino, O. Lazarov-Spiegler, E. Agranov, et al., "Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats, " Nature Medicine, vol. 4, no. 7, pp. 814-821, 1998.
128. R. Rutschman, R. Lang, M. Hesse, J. N. Ihle, T. A. Wynn, and P. J. Murray, "Cutting edge: stat6-dependent substrate depletion regulates nitric oxide production, " Journal of Immunology, vol. 166, no. 4, pp. 2173-2177, 2001.
129. K. Nakajima, Y. Tohyama, S. Kohsaka, and T. Kurihara, "Ability of ratmicroglia to uptake extracellular glutamate, " Neuroscience Letters, vol. 307, no. 3, pp. 171-174, 2001.
130. F. K. H. Van Landeghem, J. F. Stover, I. Bechmann, et al., "Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat, " Glia, vol. 35, no. 3, pp. 167-179, 2001.
131. P. G. Popovich, Z. Guan, P. Wei, I. Huitinga, N. van Rooijen, and B. T. Stokes, "Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury, " Experimental Neurology, vol. 158, no. 2, pp. 351-365, 1999.
132. L.-H. Guo, M. Mittelbronn, C. Brabeck, C. A. Mueller, and H. J. Schluesener, "Expression of interleukin-16 by microglial cells in inflammatory, autoimmune, and degenerative lesions of the rat brain, " Journal of Neuroimmunology, vol. 146, no. 1-2, pp. 39-45, 2004.
133. C.-A. Mueller, H. J. Schluesener, S. Conrad, R. Meyermann, and J. M. Schwab, "Lesional expression of a proinflammatory and antiangiogenic cytokine EMAP II confined to endotheliumand microglia/macrophages during secondary damage following experimental traumatic brain injury, " Journal ofNeuroimmunology, vol. 135, no. 1-2, pp. 1-9, 2003.
134. J. C. Fleming, M. D. Norenberg, D. A. Ramsay, et al., "The cellular inflammatory response in human spinal cords after injury, " Brain, vol. 129, no. 12, pp. 3249-3269, 2006.
135. D. P. Ankeny and P. G. Popovich, "Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury, " Neuroscience, vol. 158, no. 3, pp. 1112-1121, 2009.
136. E. Esposito and S. Cuzzocrea, "TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma, " Current Medicinal Chemistry, vol. 16, no. 24, pp. 3152-3167, 2009.
137. M. Mir, L. Tolosa, V. J. Asensio, J. Llado, and G. Olmos, "Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation, " Journal of Neuroimmunology, vol. 204, no. 1-2, pp. 101-109, 2008.
138. H. Neumann, "Major histocompatibility complex(MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha, " The Journal of Experimental Medicine, vol. 185, no. 2, pp. 305-316, 1997.
139. E. Hauben, U. Nevo, E. Yoles, et al., "Autoimmune T cells as potential neuroprotective therapy for spinal cord injury, " The Lancet, vol. 355, no. 9200, pp. 286-287, 2000.
140. E. Hauben, E. Agranov, A. Gothilf, et al., "Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease, " The Journal of Clinical Investigation, vol. 108, no. 4, pp. 591-599, 2001.
141. M. Schwartz, G. Moalem, R. Leibowitz-Amit, and I. R. Cohen, "Innate and adaptive immune responses can be beneficial for CNS repair, " Trends in Neurosciences, vol. 22, no. 7, pp. 295-299, 1999.
142. G. Moalem, R. Leibowitz-Amit, E. Yoles, F. Mor, I. R. Cohen, and M. Schwartz, "Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy, " Nature Medicine, vol. 5, no. 1, pp. 49-55, 1999.
143. L. Santambrogio, M. Benedetti, M. V. Chao, et al., "Nerve growth factor production by lymphocytes, " Journal of Immunology, vol. 153, no. 10, pp. 4488-4495, 1994.
144. M. Lotan and M. Schwartz, "Cross talk between the immune system and the nervous system in response to injury: implications for regeneration, " The FASEB Journal, vol. 8, no. 13, pp. 1026-1033, 1994.
145. N. J. Rothwell and J. K. Relton, "Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage, " Cerebrovascular and Brain Metabolism Reviews, vol. 5, no. 3, pp. 178-198, 1993.
146. Z. Zhang and L. Guth, "Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration, " Experimental Neurology, vol. 147, no. 1, pp. 159-171, 1997.
147. M. Costigan, A. Moss, A. Latremoliere, et al., "T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity, " Journal of Neuroscience, vol. 29, no. 46, pp. 14415-14422, 2009.
148. B. Zhang and J. C. Gensel, "Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord, " Experimental Neurology, vol. 258, pp. 112-120, 2014.
149. A. Ibarra, D. Correa, K. Willms, et al., "Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury, " Brain Research, vol. 979, no. 1-2, pp. 165-178, 2003.
150. P. G. Popovich, B. T. Stokes, and C. C. Whitacre, "Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system, " Journal of Neuroscience Research, vol. 45, no. 4, pp. 349-363, 1996.
151. A. Ibarra, E. Hauben, O. Butovsky, and M. Schwartz, "Thetherapeutic window after spinal cord injury can accommodate T cellbased vaccination and methylprednisolone in rats, " European Journal of Neuroscience, vol. 19, no. 11, pp. 2984-2990, 2004.
152. J. Kipnis, T. Mizrahi, E. Hauben, I. Shaked, E. Shevach, and M. Schwartz, "Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15620-15625, 2002.
153. M. Schwartz and J. Kipnis, "Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries, " Trends in Molecular Medicine, vol. 7, no. 6, pp. 252-258, 2001.
154. C. M. Grimaldi, R. Hicks, and B. Diamond, "B cell selection and susceptibility to autoimmunity, "TheJournal of Immunology, vol. 174, no. 4, pp. 1775-1781, 2005.
155. E. C. B. Milner, J. Anolik, A. Cappione, and I. Sanz, "Human innate B cells: a link between host defense and autoimmunity?" Springer Seminars in Immunopathology, vol. 26, no. 4, pp. 433-452, 2005.
156. S. K. Subudhi, M.-L. Alegre, and Y.-X. Fu, "The balance of immune responses: costimulation verse coinhibition, " Journal of Molecular Medicine, vol. 83, no. 3, pp. 193-202, 2005.
157. T. Revesz, D. Kidd, A. J. Thompson, R. O. Barnard, and W. I. McDonald, "A comparison of the pathology of primary and secondary progressive multiple sclerosis, " Brain, vol. 117, no. 4, pp. 759-765, 1994.
158. T. B. Jones, "Lymphocytes and autoimmunity after spinal cord injury, " Experimental Neurology, vol. 258, pp. 78-90, 2014.
159. J. M. Schwab, Y. Zhang, M. A. Kopp, B. Brommer, and P. G. Popovich, "The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury, " Experimental Neurology, vol. 258, pp. 121-129, 2014.
160. O. N. Hausmann, "Post-traumatic inflammation following spinal cord injury, " Spinal Cord, vol. 41, no. 7, pp. 369-378, 2003.
161. S. M. Hurst, T. S. Wilkinson, R. M. McLoughlin, et al., "IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation, " Immunity, vol. 14, no. 6, pp. 705-714, 2001.
162. C. A. Dinarello, "Historical insights into cytokines, " European Journal of Immunology, vol. 37, supplement 1, pp. S34-S45, 2007.
163. C. A. Dinarello, "Immunological and inflammatory functions of the interleukin-1 family, " Annual Review of Immunology, vol. 27, pp. 519-550, 2009.
164. J. Schmitz, A. Owyang, E. Oldhamet al., "IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, " Immunity, vol. 23, no. 5, pp. 479-490, 2005.
165. H. Tsutsui, N. Kayagaki, K. Kuida, et al., "Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice, " Immunity, vol. 11, no. 3, pp. 359-367, 1999.
166. S. I. Lee, S. R. Jeong, Y. M. Kang, et al., "Endogenous expression of interleukin-4 regulates macrophage activation and confines cavity formation after traumatic spinal cord injury, " Journal of Neuroscience Research, vol. 88, no. 11, pp. 2409-2419, 2010.
167. J. R. Plemel, V. Wee Yong, and D. P. Stirling, "Immune modulatory therapies for spinal cord injury-past, present and future, " Experimental Neurology, vol. 258, pp. 91-104, 2014.
168. E. Camand, M.-P. Morel, A. Faissner, C. Sotelo, and I. Dusart, "Long-term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cord, " European Journal of Neuroscience, vol. 20, no. 5, pp. 1161-1176, 2004.
169. L. T. McPhail, L. W. Oschipok, J. Liu, and W. Tetzlaff, "Both positive and negative factors regulate gene expression following chronic facial nerve resection, " Experimental Neurology, vol. 195, no. 1, pp. 199-207, 2005.
170. J. Wang, V. C. Asensio, and I. L. Campbell, "Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice, " Current Topics in Microbiology and Immunology, vol. 265, pp. 23-48, 2002.
171. N. J. VanWagoner, C. Choi, P. Repovic, and E. N. Benveniste, "Oncostatin M regulation of interleukin-6 expression in astrocytes, " Journal of Neurochemistry, vol. 75, no. 2, pp. 563-575, 2000.
172. J. A. Ellison, J. J. Velier, P. Spera, et al., "Osteopontin and its integrin receptor γvγ3 are upregulated during formation of the glial scar after focal stroke, " Stroke, vol. 29, no. 8, pp. 1698-1707, 1998.
173. K. M. Murphy, W. Ouyang, J. D. Farrar, et al., "Signaling and transcription in T helper development, " Annual Review of Immunology, vol. 18, pp. 451-494, 2000.
174. W. B. J. Cafferty, N. J. Gardiner, P. Das, J. Qiu, S. B. McMahon, and S. W. Thompson, "Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice, " The Journal of Neuroscience, vol. 24, no. 18, pp. 4432-4443, 2004.
175. H. Okada, T. Inoue, T. Kikuta, et al., "A possible antiinflammatory role of angiotensin II type 2 receptor in immunemediated glomerulonephritis during type 1 receptor blockade, " American Journal of Pathology, vol. 169, no. 5, pp. 1577-1589, 2006.
176. M. Farooque, J. Isaksson, and Y. Olsson, "Improved recovery after spinal cord trauma in ICAM-1 and P-selectin knockout mice, " NeuroReport, vol. 10, no. 1, pp. 131-134, 1999.
177. M. S. Ramer, J. V. Priestley, and S. B. McMahon, "Functional regeneration of sensory axons into the adult spinal cord, " Nature, vol. 403, no. 6767, pp. 312-316, 2000.
178. D. S. Rafati, Roles of NF-κB in spinal cord injury pathophysiology Ph. D. thesis, University of Texas, 2005.
179. N.-K. Liu and X.-M. Xu, "Neuroprotection and its molecular mechanism following spinal cord injury, " Neural Regeneration Research, vol. 7, no. 26, pp. 2051-2062, 2012.
180. J. Z. Pan, L. Ni, A. Sodhi, A. Aguanno, W. Young, and R. P. Hart, "Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion, " Journal of Neuroscience Research, vol. 68, no. 3, pp. 315-322, 2002.
181. P. K. Yip and A. Malaspina, "Spinal cord trauma and the molecular point of no return, " Molecular Neurodegeneration, vol. 7, no. 1, article 6, 2012.
182. P. G. Popovich, "Neuroimmunology of traumatic spinal cord injury: a brief history and overview, " Experimental Neurology, vol. 258, pp. 1-4, 2014.
183. M. Hayashi, T. Ueyama, K. Nemoto, T. Tamaki, and E. Senba, "Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury, " Journal of Neurotrauma, vol. 17, no. 3, pp. 203-218, 2000.
184. Y. L. Lee, K. Shih, P. Bao, R. S. Ghirnikar, and L. F. Eng, "Cytokine chemokine expression in contused rat spinal cord, " Neurochemistry International, vol. 36, no. 4-5, pp. 417-425, 2000.
185. G. Stoll, S. Jander, and M. Schroeter, "Microglia and macrophage responses in cerebral ischemia, " in Microglia in the Regenerating andDegenerating CentralNervous System, pp. 125-151, Springer Science and BusinessMedia, New York, NY, USA, 2002.
186. A. M. Feldman, "TNF alpha-still a therapeutic target, " Clinical and Translational Science, vol. 1, no. 2, p. 145, 2008.
187. E. Esposito and S. Cuzzocrea, "Anti-TNF therapy in the injured spinal cord, " Trends in Pharmacological Sciences, vol. 32, no. 2, pp. 107-115, 2011.
188. S. J. Choi, K. H. Lee, H. S. Park, S.-K. Kim, C.-M. Koh, and J. Y. Park, "Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes, " Yonsei Medical Journal, vol. 46, no. 6, pp. 818-826, 2005.
189. L. Bernardino, S. Xapelli, A. P. Silva, et al., "Modulator effects of interleukin-1γ and tumor necrosis factor-β on AMPAinduced excitotoxicity inmouse organotypic hippocampal slice cultures, " The Journal of Neuroscience, vol. 25, no. 29, pp. 6734-6744, 2005.
190. P. Yan, N. Liu, G.-M. Kim, et al., "Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats, " Experimental Neurology, vol. 183, no. 2, pp. 286-297, 2003.
191. J. Xu, G.-M. Kim, S. Chen, et al., "iNOS and nitrotyrosine expression after spinal cord injury, " Journal ofNeurotrauma, vol. 18, no. 5, pp. 523-532, 2001.
192. J. J. Toledo-Aral, P. Brehm, S. Halegoua, and G. Mandel, "A single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction, " Neuron, vol. 14, no. 3, pp. 607-611, 1995.
193. A. Ledeboer, J. J. P. Breve, S. Poole, F. J. H. Tilders, and A.-M. Van Dam, "Interleukin-10, interleukin-4, and transforming growth factor-β differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in cocultures of rat astroglial and microglial cells, " Glia, vol. 30, no. 2, pp. 134-142, 2000.
194. F. Wirjatijasa, F. Dehghani, R. A. Blaheta, H.-W. Korf, and N. P. Hailer, "Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-β induce ramification and reduce adhesion molecule expression of rat microglial cells, " Journal of Neuroscience Research, vol. 68, no. 5, pp. 579-587, 2002.
195. M.-S. Yang, E. J. Park, S. Sohn, et al., "Interleukin-13 and-4 induce death of activated microglia, " Glia, vol. 38, no. 4, pp. 273-280, 2002.
196. Y. Nolan, V. A. Campbell, A. E. Bolton, and M. A. Lynch, "Evidence of an anti-inflammatory role for vasogens immunemodulation therapy, " NeuroImmunoModulation, vol. 12, no. 2, pp. 113-116, 2005.
197. K. W. Park, D. Y. Lee, E. H. Joe, S. U. Kim, and B. K. Jin, "Neuroprotective role of microglia expressing interleukin-4, " Journal of Neuroscience Research, vol. 81, no. 3, pp. 397-402, 2005.
198. E. D. Ponomarev, K. Maresz, Y. Tan, and B. N. Dittel, "CNSderived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells, " Journal of Neuroscience, vol. 27, no. 40, pp. 10714-10721, 2007.
199. D. A. Kuperman and R. P. Schleimer, "Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma, " Current Molecular Medicine, vol. 8, no. 5, pp. 384-392, 2008.
200. T. Rice, J. Larsen, S. Rivest, and V. W. Yong, "Characterization of the early neuroinflammation after spinal cord injury in mice, " Journal of Neuropathology and Experimental Neurology, vol. 66, no. 3, pp. 184-195, 2007.
201. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, "IL-17 and Th17 cells, " Annual Review of Immunology, vol. 27, pp. 485-517, 2009.
202. S. Zong, G. Zeng, Y. Fang, et al., "The role of IL-17 promotes spinal cord neuroinflammation via activation of the transcription factor STAT3 after spinal cord injury in the rat, " Mediators of Inflammation, vol. 2014, Article ID 786947, 10 pages, 2014.
203. H. Gao and P. A. Ward, "STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses, " Expert Opinion on Therapeutic Targets, vol. 11, no. 7, pp. 869-880, 2007.
204. M. C. Genovese, F. Van Den Bosch, S. A. Roberson, et al., "LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proofof-concept study, " Arthritis and Rheumatism, vol. 62, no. 4, pp. 929-939, 2010.
205. K. L. Hulkowe, C. F. Brosnan, and J. W. Berman, "CSF-1 gene expression and protein levels in the central nervous system and peripheral immune system of rats with experimental autoimmune encephalomyelitis (EAE), " Journal of Neuroimmunology, vol. 35, supplement 1, p. 147, 1991.
206. M. Tani and R. M. Ransohoff, "Do chemokines mediate inflammatory cell invasion of the central nervous system parenchyma?" Brain Pathology, vol. 4, no. 2, pp. 135-143, 1994.
207. S. D. Wilson, V. K. Kuchroo, D. I. Israel, and M. E. Dorf, "Expression and characterization of TCA3: amurine inflammatory protein, " Journal of Immunology, vol. 145, no. 8, pp. 2745-2750, 1990.
208. M. Bothwell, "p75NTR: a receptor after all, " Science, vol. 272, no. 5261, pp. 506-507, 1996.
209. S. Di Giovanni, S. M. Knoblach, C. Brandoli, S. A. Aden, E. P. Hoffman, and A. I. Faden, "Gene profiling in spinal cord injury shows role of cell cycle neuronal death, " Annals of Neurology, vol. 53, no. 4, pp. 454-468, 2003.
210. K. Kasahara, T. Nakagawa, and T. Kubota, "Neuronal loss and expression of neurotrophic factors in a model of rat chronic compressive spinal cord injury, " Spine, vol. 31, no. 18, pp. 2059-2066, 2006.
211. H.-S. Kuo, M.-J. Tsai, M.-C. Huang, et al., "Acid fibroblast growth factor and peripheral nerve grafts regulateTh2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords, " Journal of Neuroscience, vol. 31, no. 11, pp. 4137-4147, 2011.
212. Y. Iwasaki, T. Shiojima, N. Tagaya, T. Kobayashi, and M. Kinoshita, "Effect of transforming growth factor γ1 on spinal motor neurons after axotomy, " Journal of the Neurological Sciences, vol. 147, no. 1, pp. 9-12, 1997.
213. H. S. Taskinen, T. Olsson, A. Bucht, M. Khademi, L. Svelander, and M. Roytta, "Peripheral nerve injury induces endoneurial expression of IFN-γ, IL-10 and TNF-α mRNA, " Journal of Neuroimmunology, vol. 102, no. 1, pp. 17-25, 2000.
214. U.-K. Hanisch, "Microglia as a source and target of cytokines, " GLIA, vol. 40, no. 2, pp. 140-155, 2002.
215. H. Linda, H. Hammarberg, S. Cullheim, A. Levinovitz, M. Khademi, and T. Olsson, "Expression of MHC class I and γ2-microglobulin in rat spinalmotoneurons: regulatory influences by IFN-gamma and axotomy, " Experimental Neurology, vol. 150, no. 2, pp. 282-295, 1998.
216. J. Brask, K. Kristensson, and R. H. Hill, "Exposure to interferon-α during synaptogenesis increases inhibitory activity after a latent period in cultured rat hippocampal neurons, " European Journal of Neuroscience, vol. 19, no. 12, pp. 3193-3201, 2004.
217. K. S. Vikman, B. Owe-Larsson, J. Brask, K. S. Kristensson, and R. H. Hill, "Interferon-γ-induced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures, " Brain Research, vol. 896, no. 1-2, pp. 18-29, 2001.
218. M. Y. Stoeckle and K. A. Barker, "Two burgeoning families of platelet factor 4-related proteins: mediators of the inflammatory response, " The New Biologist, vol. 2, no. 4, pp. 313-323, 1990.
219. R. Godiska, D. Chantry, G. N. Dietsch, and P. W. Gray, "Chemokine expression in murine experimental allergic encephalomyelitis, " Journal of Neuroimmunology, vol. 58, no. 2, pp. 167-176, 1995.
220. D. M. McTigue, M. Tani, K. Krivacic, et al., "Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury, " Journal of Neuroscience Research, vol. 53, no. 3, pp. 368-376, 1998.
221. A. De Biase, S. M. Knoblach, S. Di Giovanni, et al., "Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity, " Physiological Genomics, vol. 22, pp. 368-381, 2005.
222. K. Shibuya, S. Misawa, K. Arai, et al., "Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study, " Experimental Neurology, vol. 232, no. 2, pp. 149-153, 2011.
223. G. Song, C. Cechvala, D. K. Resnick, R. J. Dempsey, and V. L. R. Rao, "GeneChip- analysis after acute spinal cord injury in rat, " Journal of Neurochemistry, vol. 79, no. 4, pp. 804-815, 2001.
224. M. Kerschensteiner, E. Gallmeier, L. Behrens, et al., "Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?" Journal of Experimental Medicine, vol. 189, no. 5, pp. 865-870, 1999.
225. Z. Zhou, X. Peng, R. Insolera, D. J. Fink, and M. Mata, "IL promotes neuronal survival following spinal cord injury, " Experimental Neurology, vol. 220, no. 1, pp. 183-190, 2009.
226. R. E. White, M. Rao, J. C. Gensel, D. M. McTigue, B. K. Kaspar, and L. B. Jakeman, "Transforming growth factor γ transforms astrocytes to a growth-supportive phenotype after spinal cord injury, " The Journal of Neuroscience, vol. 31, no. 42, pp. 15173-15187, 2011.
227. C. D. Thompson, J. C. Zurko, B. F. Hanna, D. J. Hellenbrand, and A. Hanna, "The therapeutic role of interleukin-10 after spinal cord injury, " Journal of Neurotrauma, vol. 30, no. 15, pp. 1311-1324, 2013.
228. S.-M. Lucas, N. J. Rothwell, and R. M. Gibson, "The role of inflammation in CNS injury and disease, " British Journal of Pharmacology, vol. 147, no. 1, pp. S232-S240, 2006.
229. F. P. Eckenstein, T. McGovern, D. Kern, and J. Deignan, "Neuronal vulnerability in transgenic mice expressing an inducible dominant-negative FGF receptor, " Experimental Neurology, vol. 198, no. 2, pp. 338-349, 2006.
230. J.-C. Wu, W.-C. Huang, Y.-C. Chen, et al., "Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial, " Journal of Neurosurgery: Spine, vol. 15, no. 3, pp. 216-227, 2011.
231. A. W. Bannon, J. Seda, M. Carmouche, et al., "Behavioral characterization of neuropeptide Y knockout mice, " Brain Research, vol. 868, no. 1, pp. 79-87, 2000.
232. G. Marsicano and B. Lutz, "Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain, " European Journal of Neuroscience, vol. 11, no. 12, pp. 4213-4225, 1999.
233. Z. Wiesenfeld-Hallin, G. de Arauja Lucas, P. Alster, X.-J. Xu, and T. Hokfelt, "Cholecystokinin/opioid interactions, " Brain Research, vol. 848, no. 1-2, pp. 78-89, 1999.
234. S. Sanjabi, L. A. Zenewicz, M. Kamanaka, and R. A. Flavell, "Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity, " Current Opinion in Pharmacology, vol. 9, no. 4, pp. 447-453, 2009.
235. H. Thoenen, "The changing scene of neurotrophic factors, " Trends in Neurosciences, vol. 14, no. 5, pp. 165-170, 1991.
236. M. Barbacid, "Structural and functional properties of the TRK family of neurotrophin receptors, " Annals of the New York Academy of Sciences, vol. 766, pp. 442-458, 1995.
237. Z. Hajebrahimi, S. J. Mowla, M. Movahedin, and M. Tavallaei, "Gene expression alterations of neurotrophins, their receptors and prohormone convertases in a rat model of spinal cord contusion, " Neuroscience Letters, vol. 441, no. 3, pp. 261-266, 2008.